“HOT” stock: ResMed (RMD)
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk explains why Morgans regards ResMed (RMD) as a BUY.
Expert buy, hold and sell recommendations from our team of analysts.
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk explains why Morgans regards ResMed (RMD) as a BUY.
Here are three more stocks that look to be good buying opportunities at current prices.
The price of copper and gold have been boosted by bullish short-term sentiment, but as always I believe investors should also continue to take a long-term view.
For the week ending Friday, January 30, 2026, FNArena tracked twenty-four upgrades and twenty-six downgrades for ASX-listed companies from brokers monitored daily.
This week on Switzer Investing TV, the focus turns to stock selection, as three experienced investors share where they’re finding opportunity after a volatile start to the year.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.